| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H12O4 |
| Molecular Weight | 268.2641 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C2=COC3=C(C=CC(O)=C3)C2=O
InChI
InChIKey=HKQYGTCOTHHOMP-UHFFFAOYSA-N
InChI=1S/C16H12O4/c1-19-12-5-2-10(3-6-12)14-9-20-15-8-11(17)4-7-13(15)16(14)18/h2-9,17H,1H3
Formononetin, an isoflavone, derived from Astragalus membranaceus, possesses the potential to reduce obesity and associated metabolic disorders. Formononetin displays estrogenic properties and induces angiogenesis activities. It regulates adipocyte thermogenesis as a partial PPARγ agonist and produces proangiogenesis effects through estrogen receptor alpha (ERα)-enhanced ROCK-II signaling pathways, by direct binding to the ligand-binding domain (LBD) of ERα. Besides, was shown, that formononetin inhibits HMGB1 release by decreasing HMGB1 acetylation via upregulating SIRT1 in a PPARδ-dependent manner and the identification of this process may help to treat inflammation-related disorders.
Approval Year
Sample Use Guides
The mice were fed on a high fat diet (D12492, Research Diets) for 8 weeks to become obese, and then randomly divided into two groups and gavaged for the following 8 weeks with either Astragalus membranaceus water extract (3.3g/kg) or formononetin (50mg/kg) and vehicle (control) on a high fat diet.
Route of Administration:
Oral
SUBSTANCE RECORD
